Skip to main content

Replacing the Animal Source of Viscous Fluids Used in Cataract Surgery with the Okra Plant Source

Cel

Eye cataracts, leading to the loss of vision present a major problem for the aging population. This is currently cured by surgical procedure which requires a viscoelastic High Molecular Weight (HMW) product of Ophthalmic Viscosurgical Device to fill the space in the eye created during the surgery and to protect the healthy endothelial cells. Due to the growing elderly population, this market segment is expected to grow at least 7% per year and will reach €80 Mn in the EU and €240 Mn worldwide by 2014. The market need for (HMW) products is currently served by Hyaluronic acid (HA) and cheaper alternatives derived from cellulose with properties inferior to HA. The manufacturers have currently to rely on few suppliers of the high-quality raw materials i.e. roosters bred on a special diet. The animal nature of the raw materials makes the SMEs particularly vulnerable in light of a bird flu outbreak, creating the threat of losing up to an entire year supply of the raw material with a single outbreak in the region. In addition, using raw materials of animal origin in humans requires compliance with existing EU regulations (EC 1774/2002 and Directive 90/426/EEC, and also Directive 86/609/EEC, 3 R’s Declaration, and REACH). Hence EU SMEs such as ourselves realize that we should switch to a non-animal source of HMW substance, as a substitute to rooster combs originating HA. The main objective of the OkraVision project is to substitute animal based production of HMW HA with a cheaper and non-animal HMW substance: Rhamnopyranose–Galactopyranose–Galactopyranosyluronic Acid (RGGA) from the okra plant (fruit) with the targeted chain length of 800-1000 units, MW of 5-6 MDa, and the targeted zero shear viscosity of 1-3 Mn mPas for 1-2.5% aqueous solution. This will be done by developing a continuous and automised extraction and purification process of HMW RGGA from the okra fruit with a production efficiency of 3 g of RGGA from 1 kg (0.3% weight-to-weight) of sliced okra fruit.

Zaproszenie do składania wniosków

FP7-SME-2012
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

BOHUS BIOTECH AB
Adres
Tradgardsgatan 4
452 31 Stromstad
Szwecja
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Wkład UE
€ 416 865
Kontakt administracyjny
Daniel C. Ogbonnaya (Mr.)

Uczestnicy (6)

SLATTUM PRODUKTER AS
Norwegia
Wkład UE
€ 136 989
Adres
Tyriv 5
1481 Hagan
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt administracyjny
Pål Fredriksen (Mr.)
INDUSTRIAL CONTROL SOLUTIONS LIMITED
United Kingdom
Wkład UE
€ 248 690,12
Adres
Carlton Road Enterprise House
S81 7QF Worksop
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt administracyjny
Steve Mcdermott (Mr.)
PRC ENGINEERING AB
Szwecja
Wkład UE
€ 281 526,48
Adres
Regnbagsgatan 8 B
417 55 Goteborg
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt administracyjny
Mattias Carlsson (Mr.)
OSAUHING EESTI INNOVATSIOONI INSTITUUT
Estonia
Wkład UE
€ 6 989,40
Adres
Sepapaja 6
11415 Tallinn
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt administracyjny
Lauri Nirgi (Mr.)
NOVAMINA CENTAR INOVATIVNIH TEHNOLOGIJA DOO
Chorwacja
Wkład UE
€ 5 217
Adres
Jackovinsli Klanec 17
10000 Zagreb
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt administracyjny
Jasmina Petrinovic (Mrs.)
MDT MEDICAL DEVICE TESTING GMBH
Niemcy
Wkład UE
€ 8 723
Adres
Grenzenstrasse 13
88416 Ochsenhausen
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt administracyjny
Dieter R. Dannhorn (Dr.)